Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Arthralgia-associated aging perceptions predict adherence to aromatase inhibitors among women with breast cancer
    Meeting Abstract

    Mao, J. J.; Chambless, D. L.; Chen, J.; Bao, T.; Brier, M. J.
    Cancer Research (2017)

    Fulltext@MSK | Save
  • The genomic landscape of breast metaplastic carcinoma
    Meeting Abstract

    Geyer, F. C.; Ng, C. K.; Piscuoglio, S.; Wen, Y. H.; Wen, H. C.; Pareja, F.; Eberle, C. A.; Burke, K. A.; Lim, R. S.; Natrajan, R.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Intra-tumor genetic heterogeneity and histologic heterogeneity within metaplastic breast cancers: Genotypic-phenotypic correlations
    Meeting Abstract

    Geyer, F. C.; Burke, K. A.; Papanastatiou, A. D.; Macedo, G. S.; Brogi, E.; Norton, L.; Wen, Y. H.; Weigelt, B.; Reis, J. S.
    Cancer Research (2017)

    Fulltext@MSK | Save
  • A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
    Meeting Abstract

    Goldfarb, S. B.; Konner, J.; Stevens, J.; Brouwer, S.; Narain, N. R.; Ye, R.; Ravipaty, S.; Sarangarajan, R.; Akmaev, V. R.; Jimenez, J. J.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • A phase I study of AZD9496, a novel oral, selective estrogen receptor degrader (SERD) in women with estrogen receptor positive, HER-2 negative advanced breast cancer (ABC)
    Meeting Abstract

    Hamilton, E.; Patel, M.; Armstrong, A.; Baird, R.; Jhaveri, K.; Hoch, M.; Morgan, S.; Dowdall, T.; Schiavon, G.; Klinowska, T.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Efficacy and tolerability of veliparib (V; ABT-888) in combination with carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer: A randomized, phase 2 study
    Meeting Abstract

    Han, H. S.; Dieras, V.; Robson, M. E.; Palacova, M.; Marcom, P. K.; Jager, A.; Bondarenko, I.; Citrin, D.; Campone, M.; Telli, M. L.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Metabolic obesity, adipose inflammation and aromatase: Potential drivers of breast cancer risk in women with normal body mass index
    Meeting Abstract

    Iyengar, N. M.; Arown, K.; Khou, X.; Subbaramaiah, K.; Giri, D. D.; Gucalp, A.; Howe, L. R.; Zahid, H.; Bhardwaj, P.; Wendel, N. K.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Targeting inflammatory pathways: A phase 2 trial of the JAK-inhibitor ruxolitinib in combination with exemestane for aromatase inhibitor-resistant, estrogen receptor-positive breast cancer
    Meeting Abstract

    DeMichele, A. M.; Clark, A. S.; Holmes, R.; Volpe, M.; Medrano, C.; Troxel, A.; Fox, K.; Domchek, S.; Matro, J.; Bradbury, A.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • ENDEAR: A randomized international phase 3 study comparing the efficacy and safety of enzalutamide in combination with paclitaxel chemotherapy or as monotherapy vs placebo with paclitaxel in patients with advanced diagnostic-positive triple-negative breast cancer
    Meeting Abstract

    Dent, R.; Schmid, P.; Cortes, J.; Kim, S. B.; Andre, F.; Abramson, V.; Cardoso, F.; Colleoni, M.; Morris, P.; Steinberg, J.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Evaluation of veliparib (V) and temozolomide (TMZ) in a phase 2 randomized study of the efficacy and tolerability of V plus TMZ or carboplatin (C) and paclitaxel (P) vs placebo (Plc) plus C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer
    Meeting Abstract

    Dieras, V.; Han, H. S.; Robson, M. E.; Palacova, M.; Marcom, P. K.; Jager, A.; Bondarenko, I.; Citrin, D.; Campone, M.; Telli, M. L.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save